Print this page    •   Back to Web version of article

U.S. News
Alternative Approaches to Partner Notification, Diagnosis, and Treatment: Pharmacists' Perspectives on Proposed Patient Delivered Partner Therapy in New York State, 2007

March 13, 2009

"Supported by the American Medical Association, patient delivered partner therapy (PDPT) is becoming legal in many states. For some individuals exposed to sexually transmitted infections [STIs], the pharmacist may become the sole point of contact with the medical system," the researchers explained. The current study examined pharmacists' perceptions about PDPT, education on STIs, and potential barriers to successful implementation of PDPT.

A survey of pharmacists was conducted, and privacy-related spaces in pharmacies were observed. In eight counties of the Capital Region of New York state, all community pharmacies were invited to participate. In eight additional counties, convenience sampling was utilized. The overall response proportion was 67.3 percent.

Of 193 pharmacists who responded, 63 percent supported PDPT for chlamydia and 78 percent said they did not want a behind-the-counter status for antibiotics used to treat the infection. The majority (88 percent) desired that prescriptions be marked as PDPT so as to alert them to counseling needs. About half the pharmacists said they would automatically submit PDPT prescriptions to insurance companies -- a confidentiality issue. Patient counseling time was the most frequently cited barrier (49 percent).

"Pharmacists are open to considering PDPT as part of their professional functions," the researchers found. "Although pharmacists need additional [STI] education in general, capacity for this training can be developed. Confidentiality issues remain a priority issue to address to protect individuals treated through PDPT."

Back to other news for March 2009

Excerpted from:
Sexually Transmitted Diseases
03.2009; Vol. 36; No. 3: P. 178-184; Louise-Anne McNutt, Ph.D.; Christopher F. Davis, M.P.H.; Robert A. Bednarczyk, M.S.; Andrea Fischer, M.P.H.; Mario Zeolla, Pharm.D.; Bruce F. Coles, D.O.

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.